Stocks & Investing
Stocks and Investing
Stocks and Investing
Mon, November 4, 2019
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
Fri, November 1, 2019
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
Whit Mayo Upgraded (AMED) to Buy on, Nov 1st, 2019
Whit Mayo of Baird, Upgraded "Amedisys, Inc." (AMED) to Buy on, Nov 1st, 2019.
Whit has made no other calls on AMED in the last 4 months.
There are 3 other peers that have a rating on AMED. Out of the 3 peers that are also analyzing AMED, 1 agrees with Whit's Rating of Hold. Following is the relevant analyst calls for the last 4 months
- Scott Fidel of "Stephens & Co." Initiated at Hold and Held Target at $145 on, Tuesday, October 22nd, 2019
These are the ratings of the 2 analyists that currently disagree with Whit
- Justin Bowers of "Deutsche Bank" Initiated at Strong Buy and Held Target at $155 on, Tuesday, September 17th, 2019
- John Ransom of "Raymond James" Maintained at Buy with Increased Target to $144 on, Monday, July 15th, 2019
